Attached files

file filename
8-K - FORM 8-K - Shire plcdp34091_8k.htm
EX-99.2 - EXHIBIT 99.02 - Shire plcdp34091_ex9902.htm
Exhibit 99.01
 
Press Release
www.shire.com
 
 
Notification of major interests in shares

 
November 6, 2012 - Shire plc (LSE: SHP, NASDAQ: SHPG)
 
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
 
Shire plc
2. Reason for the notification
State
Yes/No
An acquisition or disposal of voting rights
Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
No
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
Yes
An event changing the breakdown of voting rights
No
Other (please specify):
No

3. Full name of person(s) subject to the notification obligation:
BlackRock Inc
 
4. Full name of shareholder(s) (if different from 3.):
N/A
5. Date of the transaction (and date on which the threshold is crossed or reached if different):
2 November 2012
6. Date on which issuer notified:
6 November 2012
7. Threshold(s) that is/are crossed or reached:
Above 10%

8. Notified details:
A: Voting rights attached to shares
 
 
Class/type of shares
 if possible using the ISIN CODE
Situation previous to
the Triggering
transaction
Resulting situation after the triggering
transaction
Number
of
Shares
Number
of
Voting
Rights
 
Number
of
shares
Number of voting
rights
% of voting
rights
 
Direct
Indirect
Direct
Indirect
JE00B2QKY057
33,336,203
 
33,336,203
 
N/A
 
N/A
 
54,260,621
N/A
 
9.66%
 
B: Qualifying Financial Instruments
 
Resulting situation after the triggering transaction
 
Type of financial
instrument
Expiration
date
Exercise/Conversion
Period/ Date
Number of voting
rights that may be
acquired if  the instrument
is exercised/converted
% of voting
rights
         
 
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
 
 

 

 
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
 
Resulting situation after the triggering transaction
 
Type of financial
instrument
Exercise
price
Expiration
date
Exercise/
Conversion
period
Number of voting
rights instrument
refers to
% of voting rights
 
 CFD
 
 
 
 2,272,938
Nominal
Delta
 
 0.40%
 0.40%

Total (A+B+C)
 
Number of voting rights
% of voting rights
56,533,559
10.06

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
 
BlackRock Investment Management (UK) Limited – 56,533,559 (10.06%)
 

Proxy Voting:
 
10. Name of the proxy holder:
 
 
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A

13. Additional information:
BlackRock Regulatory Threshold Reporting Team
14. Contact name:
Wayne Powell
15. Contact telephone number:
020 7743 2216; wayne.powell@blackrock.com

Contact at Shire plc: Tony Guthrie, Deputy Company Secretary, 01256 894746

For further information please contact:

Investor Relations
   
Eric Rojas
erojas@shire.com
+1 781 482 0999
Sarah Elton-Farr
seltonfarr@shire.com
+44 1256 894157

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:

·  
Behavioral Health and Gastro Intestinal conditions
·  
Rare Diseases
·  
Regenerative Medicine

as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.